Cookies


ESHRE ® uses cookies to improve your browsing experience on its website, as defined in the Cookie Policy (as updated on 18/03/2024). Strictly necessary cookies are necessary for the proper functioning of the Website – therefore, you cannot refuse them. Other, non-strictly necessary cookies are only placed if you consent to their use. Read more about it in our Cookie Policy. Do you agree with our use of non-strictly necessary cookies?
Manage my cookie preferences

Make time for your development – Explore the ESHRE Campus events

Update information

Section

Change Description

Version

Publication date

All

Full revision of the guideline

Oct 2025

10-14-2025

6.A r-hFSH biosimilar preparations

The section titled recombinant (r-hFSH) biosimilar preparations has been temporarily removed from the guideline while the guideline group conducts a further review of the evidence and conclusions.

Oct 2025_v2.1

10-29-2025

Change log

A version history of changes to the guideline was added.

Nov 2025_v2.2

11-13-2025
 6.A r-hFSH biosimilar   preparations The section titled recombinant (r-hFSH) biosimilar preparations was reintroduced after further review of the evidence and conclusions, stakeholder review and ExCO approval.  Sept 2026_v2.3   09-22-2026

Older versions of the guidelines are available upon request to guidelines@eshre.eu